• Focus:
    Health economics and outcomes research writing, type 2 diabetes, other therapeutic areas
  • For Inquires Call:
  • Contact:
    Caitlin Rothermel,
  • Expertise:
    Budget Impact
    Emerging Markets
    Health Policy, Reform, Delivery
    HEOR General
    LatePhase Research
    Market Access
    Patient-Reported Outcomes
Listing Overview

MedLitera is a small, specialized virtual firm that provides high-quality medical and health economics writing services.

When you work with MedLitera, you have access to the expertise of a group of professionals whose range is a unique strength. Our writers, editors, and researchers are versed in both the clinical and economic aspects of health care and are comfortable writing for any audience.

The types of health economics and outcomes research (HEOR) content we have developed includes:

  • Retrospective database analyses, cost-effectiveness publications, and other original research for publication
  • Value dossiers targeted to key payer/purchaser audiences
  • Academy of Managed Care Pharmacy (AMCP) dossiers and other technical reimbursement dossiers
  • Product- or disease-specific systematic reviews and/or competitive analyses that synthesize clinical and health economics research
  • White papers, blogs, and targeted communications that describe the health and financial impact of new treatments and technologies

Click here to see some publications we have written. Other samples are available on request.

Click here to read Caitlin Rothermel’s health economics-related blog postings on tHEORetically Speaking.

Our clients include: The American Association of Clinical Endocrinologists (AACE), Bristol-Myers Squibb, IMS Health, Joslin Diabetes Center, Precision Health Economics, and St. Jude Medical.

No video attached.
Write Review

One review on “MedLitera

    I’ve employed Caitlin Rothermel and her team at MedLitera several times over the past few years, and I’ve also referred clients to her. Without fail, Caitlin has delivered high quality, scientifically robust, and customer-centric medical writing for the HEOR-focused audience of payers, clinicians, and technology assessment reviewers. I recommend her without fail.